US FDA declines to approve Applied Therapeutics' genetic disease drug

Applied Therapeutics

27/11/2024 21:14

Nov 27 (Reuters) - The U.S. Food and Drug Administration
on Wednesday declined to approve Applied Therapeutics'  APLT.O 
drug to treat galactosemia, a rare genetic metabolic disease,
the company said.

 (Reporting by Sneha S K, Mariam Sunny and Christy Santhosh in
Bengaluru; Editing by Shailesh Kuber)
 ((Sneha.SK@thomsonreuters.com))